Ozoralizumab (ATN-103) is an anti-TNFalpha humanized antibody. Ozoralizumab is a humanized trivalent nanobody compound that consists of two anti-human TNFalpha nanobodies and an anti-human serum albumin (HSA) nanobody. Ozoralizumab can be used in research of arthritis[1].
Molecular Weight:
(38.43 kDa)
Purity:
99.80
CAS Number:
[1167985-17-2]
Target:
TNF Receptor
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted